HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Du, K. Articles by Montminy, M. Search for Related Content PubMed PubMed Citation Articles by Du, K. Articles by Montminy, M. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 49, 32377-32379, December 4, 1998

COMMUNICATION
CREB Is a Regulatory Target for the Protein Kinase Akt/PKB^*

Keyong Du and Marc Montminy

From the Joslin Diabetes Center, Research Division, Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02215

	ABSTRACT

Top Abstract Introduction Procedures Results & Discussion References

The nuclear factor CREB stimulates the expression of cellular genes following its protein kinase A-mediated phosphorylation at Ser-133. Ser-133 phosphorylation, in turn, activates target gene expression by promoting recruitment of the co-activator CBP. Recent studies showing that CREB and its paralog CREM are required for survival of certain cell types prompted us to examine whether CREB is a nuclear target for activation via the growth factor-dependent Ser/Thr kinase Akt/PKB. When overexpressed in serum-stimulated cells, Akt/PKB potently induced Ser-133 phosphorylation of CREB and promoted recruitment of CBP. Correspondingly, Akt/PKB stimulated target gene expression via CREB in a phospho(Ser-133)-dependent manner. Akt/PKB induced CREB activity only in response to serum stimulation, and this effect was suppressed by the phosphatidylinositol 3-kinase inhibitor LY 294002. Our results support the notion that Akt/PKB promotes cell survival, at least in part, by stimulating the expression of cellular genes via the CREB/CBP nuclear transduction pathway.

	INTRODUCTION

Top Abstract Introduction Procedures Results & Discussion References

Originally characterized on the basis of its sequence homology with the v-Akt oncogene and with protein kinase A (1-3), the Ser/Thr kinase Akt has been shown to block cellular apoptosis and to promote cell survival in response to growth factor induction (reviewed in Ref. 4). Akt/PKB-mediated phosphorylation of BAD, for example, blocks cellular apoptosis by promoting binding of BAD to the 14-3-3 protein and thereby sequestering BAD from Bcl-X_L (5-7). Following activation by PI3-K,¹ Akt/PKB translocates to the nucleus where it is thought to regulate specific genetic programs by catalyzing the phosphorylation of specific nuclear factors (8, 9).

A number of growth factors and hormones have been shown to stimulate the expression of cellular genes by inducing the phosphorylation of the nuclear factor CREB at Ser-133 (reviewed in Ref. 10). Originally characterized as a target for PKA-mediated phosphorylation (11), CREB is also recognized by other cellular kinases including protein kinase C (12), pp90^RSK (13), calmodulin kinases II and IV (14, 15), and microtubule-activated protein kinase-activated protein 2 (16).

Recent studies with transgenic and knockout mice indicate that CREB and its paralog CREM are important for cell survival. CREM-deficient mice, for example, exhibit a spermatogenesis defect secondary to enhanced apoptosis of germ cells (17, 18). Overexpression of a dominant negative CREB transgene, moreover, induces apoptosis in T cells, following growth factor stimulation (19). The involvement of CREB family members in cell survival and the resemblance of Akt/PKB to protein kinase A, not only in primary sequence but also in its apparent substrate specificity, prompted us to examine whether CREB is a regulatory target for Akt/PKB. Here we demonstrate that Akt/PKB promotes phosphorylation of CREB, stimulates recruitment of CBP to the promoter, and activates cellular gene expression via a CRE-dependent mechanism. Our results suggest that CREB may contribute importantly to cell survival in response to growth factor stimulation.

	EXPERIMENTAL PROCEDURES

Top Abstract Introduction Procedures Results & Discussion References

Cell Culture and Transfections-- 293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. For transfection assay, cells were plated at 1.5 × 10⁵ cells/well 24 h prior to transfection. Cells were transfected with Lipofectin reagent supplied by Life Technologies, Inc. For assays with GAL4 CREB expression vector, each transfection contained 0.5 µg of G5B CAT, 0.5 µg of HA-tagged Akt/PKB expression plasmid, 0.25 µg of GAL4-CREB expression plasmid, plus 0.5 µg of RSV -galactosidase expression vector as internal control. Total amount of plasmid was adjusted to 1.75 µg with empty CMV expression vector. Cells were harvested 36-40 h post-infection. For PI3-K inhibitor studies in Fig. 3C, transfected cells were treated with 10% serum plus Me₂SO vehicle or 10% serum plus 20 µM LY 294002 for 24 h. CAT activity was quantitated with a PhosphorImager after normalizing to -galactosidase activity.

For mammalian two-hybrid studies 293T cells were transfected with 0.25 µg of GAL4KID, 0.25 µg of KIX VP16, 0.5 µg of Akt/PKB expression vector, and 0.5 µg of RSV -galactosidase as normalization control. In assays where KIX VP16 was omitted, VP16 expression vector was added in place.

In Vitro Kinase Assays-- 293T cells (1 × 10⁶) were transfectd with 8 µg of HA-tagged wild-type or kinase-inactive Akt/PKB expression plasmid using Lipofectin reagent. Cells were harvested 36 h post-transfection and lysed in buffer containing 20 mM HEPES (pH 7.5), 420 mM NaCl, 5 mM MgCl₂, 1% Nonidet P-40, 10% glycerol, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, and 1 mM okadaic acid. After removing cell debris by centrifugation at 13,500 for 10 min, lysates were pre-cleared by incubation with agarose-protein A/G resin and then incubated with anti-HA monoclonal antiserum (16B12, Babco) for 4 h. Anti-HA Akt/PKB complexes were then collected by incubation with agarose-protein A/G resin, and these immunoprecipitates were used in in vitro kinase assays containing [-³²P]ATP and 1 µg of recombinant CREB protein. Reactions were terminated by addition of 2× SDS loading buffer.

	RESULTS AND DISCUSSION

Top Abstract Introduction Procedures Results & Discussion References

To determine whether CREB is a regulatory target for Akt/PKB, we performed in vitro kinase assays with HA-tagged wild-type and mutant forms of Akt/PKB following transfection in 293T cells. Immunoprecipitates of HA-tagged Akt/PKB phosphorylated recombinant CREB protein in vitro (Fig. 1). Lower levels of Ser-133 kinase activity were recovered from Akt/PKB immunoprecipitates prepared from serum-deprived cells compared with serum-stimulated cells, indicating that Akt/PKB must be activated to phosphorylate CREB (Fig. 1). These results are consistent with previous reports showing that serum stimulation activates Akt/PKB kinase activity (9). By contrast, no CREB kinase activity was recovered from immunoprecipitates of 293T cells expressing kinase-inactive K179M mutant HA-Akt/PKB (20), indicating that the effect of Akt/PKB on CREB phosphorylation is likely to be direct (Fig. 1).

View larger version (18K): [in this window] [in a new window]   Fig. 1.   Akt/PKB phosphorylates CREB in response to serum stimulation. A, top, autoradiogram of 32P-labeled recombinant CREB following incubation with immunoprecipitates of wild-type Akt/PKB (WT) or kinase-inactive (MT) Akt/PKB prepared from transfected 293T cells. Immunoprecipitates of Akt/PKB from serum-treated (+) or serum-deprived () cells indicated over each lane. Bottom, Western blot of whole cell lysates from transfected cells using anti-HA antiserum ( HA) to detect HA-tagged wild-type Akt/PKB and mutant Akt/PKB polypeptides. B, top, autoradiogram of 32P-labeled recombinant wild-type CREB (WT) and Ser-133  Ala (M1) CREB polypeptides following incubation with immunoprecipitates of wild-type Akt/PKB from transfected 293T cells. Bottom, Coomassie Blue-stained gel of recombinant wild-type CREB and Ser-133  Ala mutant CREB polypeptides used for phosphorylation assay above.

To test whether Akt/PKB-mediated phosphorylation of CREB is sufficient to stimulate recruitment of CBP, we performed mammalian two-hybrid studies in 293T cells using relevant interaction domains in CREB and CBP, referred to as KID and KIX, respectively. Overexpression of wild-type Akt/PKB stimulated recruitment of a KIX-VP16 fusion protein to GAL4-KID about 10-fold, as evaluated on a G5B CAT reporter containing five GAL4 recognition sites (Fig. 2A). By contrast, kinase-inactive mutant Akt/PKB had no stimulatory effect on G5B CAT reporter activity, demonstrating the importance of Akt/PKB-mediated phosphorylation for induction of the CREB·CBP complex.

View larger version (9K): [in this window] [in a new window]   Fig. 2.   Akt/PKB stimulates recruitment of CBP to CREB and activation of cAMP responsive genes. A, mammalian two-hybrid assay of 293T cells using GAL4-KID and KIX-VP16 expression vectors containing interaction domains of CREB and CBP, respectively. Interaction between KID and KIX domains was evaluated by measuring induction of co-transfected G5B CAT reporter plasmid in 293T cells. Cells transfected with GAL4-KID (KID) or GAL4-KID plus KIX-VP16 expression vectors (KID+KIX) indicated below each set of bars. Open bars, MT-Akt; black bars, WT-Akt. B, WT-Akt, reporter activity in cells transfected with wild-type Akt/PKB expression plasmid. MT-Akt, activity in cells expressing Lys-179  Met inactive Akt/PKB. Relative CAT activity derived from CRE-CAT (11) reporter plasmid after normalizing to activity from co-transfected RSV -galatosidase plasmid.

Based on its ability to promote recruitment of CBP to CREB, we examined whether Akt/PKB correspondingly induces target gene expression via this pathway. When overexpressed in 293T cells, wild-type Akt/PKB but not kinase-inactive Akt/PKB stimulated a CRE-CAT reporter about 15-fold (Fig. 2B). To rule out regulatory contributions from other CRE binding proteins and to evaluate the importance of Ser-133 phosphorylation for induction via Akt/PKB, we performed transfection assays with GAL4 CREB polypeptides in which the CREB trans-activation domain (amino acids 1-283) is fused to the GAL4 DNA-binding domain (amino acids 1-147). Following transfection into 293T cells, wild-type Akt/PKB stimulated GAL4-CREB activity 20-fold relative to kinase-inactive Akt/PKB in 293T cells (Fig. 3A). By contrast, wild-type Akt/PKB had no effect on the activity of a Ser-133  Ala GAL4 CREB (GAL4-M1)mutant polypeptide, indicating that this kinase stimulates CREB activity via phosphorylation at Ser-133. Indeed, Western blot analysis of whole cell lysates from transfected 293T cells revealed that the wild-type GAL4-CREB polypeptide was phosphorylated in cells expressing wild-type Akt/PKB but not kinase-inactive Akt/PKB (Fig. 3B).

View larger version (20K): [in this window] [in a new window]   Fig. 3.   Akt/PKB stimulates CREB activity in vivo via a Ser-133-dependent mechanism. A, transient assay of 293T cells transfected with wild type (GAL4 CREB) or Ser-133  Ala mutant (GAL4-M1) expression vectors containing the GAL4 DNA-binding domain fused N-terminally to full-length CREB cDNA. GAL4 CREB activity was measured with G5B CAT reporter plasmid containing five GAL4 recognition sites. CAT activity derived from cells co-transfected with wild-type Akt/PKB (WT-Akt, black bars) or kinase-inactive (MT-Akt, open bars) Akt/PKB expression plasmids. B, Akt/PKB stimulates phosphorylation of GAL4 CREB at Ser-133 in vivo. Western blot assays of wild-type GAL4 CREB using phospho(Ser-133)-specific (P-CREB) or nondiscriminating CREB antisera (CREB). Expression of wild type (WT) and mutant (MT) Akt/PKB polypeptides from the same 293T cell lysates was evaluated using  HA antiserum. C, serum treatment induces Akt/PKB-mediated activation of CREB via a PI3-K-dependent mechanism in 293T cells. CAT assay of 293T cells transfected with wild-type Akt/PKB and GAL4-CREB expression vectors. Following transfection, cells were either serum-deprived (NONE), maintained in medium containing 10% fetal calf serum (10%), or treated with PI3-K-specific inhibitor LY 294002 (10%+LY).

In keeping with its effects on CREB phosphorylation in vitro, serum treatment promoted Akt/PKB induction of Gal4 CREB activity in 293T cells about 3-4-fold compared with serum-deprived cells (Fig. 3C). Following serum stimulation, Akt/PKB appears to be activated by PI3-K (9, 20). To test whether CREB activation proceeds via a similar mechanism, we treated 293T cells with the PI3-K inhibitor LY 294002. Compared with serum-stimulated cells, 293T cells blocked with LY 294002 compound showed far lower GAL4 CREB activation in response to Akt/PKB, demonstrating that the PI3-K pathway is indeed required for this effect (Fig. 3C).

Taken together, our results indicate that Akt/PKB stimulates cellular gene expression in part via the phosphorylation of CREB at Ser-133. We cannot exclude the possibility, however, that an Akt/PKB-associated kinase and not Akt/PKB per se phosphorylates CREB directly. The ability of Akt/PKB to promote target gene activation is unusual because other second messengers such as phosphoinositol, although inducing Ser-133 phosphorylation to high stoichiometry, do not promote target gene activation (21). Co-immunoprecipitation and mammalian two-hybrid studies indicate that the block in target gene activation occurs at the level of CREB·CBP complex formation (21). The mechanism underlying signal discrimination via CREB/CBP is unclear, but current data favor a secondary phosphorylation event on CREB that would inhibit complex formation with CBP. In this regard, Maurer and colleagues have observed that secondary phosphorylation of phospho(Ser-133) CREB at Ser-142 strongly inhibits target gene activation (14). It will be interesting to determine whether and to what degree Ser-142 is phosphorylated in vivo following stimulation via pathways that do or do not promote target gene activation.

Recent studies indicate that CREB functions importantly in promoting cell survival. Targeted disruption of the CREB gene, for example, leads to a defect in spermatogenesis secondary to germ cell apoptosis (17, 18). Overexpression of a dominant negative CREB transgene, moreover, induces T cell apoptosis in response to growth factor stimulation (19). Characterizing target genes that are activated via CREB will further clarify the mechanism by which Akt/PKB promotes cell survival.

	FOOTNOTES

^* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Joslin Diabetes Center, Joslin Place, Boston, MA 02215. Tel.: 617-735-1926; Fax: 617-735-1928; E-mail: montminm{at}joslab.harvard.edu.

The abbreviations used are: PI3-K, phosphatidylinositol 3-kinase; CAT, chloramphenicol acetyltransferase; HA, hemagglutinin; RSV, Rous sarcoma virus.

	REFERENCES

Top Abstract Introduction Procedures Results & Discussion References

1. Coffer, P., and Woodgett, J. (1991) Eur. J. Biochem. 201, 475-481[Medline] [Order article via Infotrieve]
2. Jones, P., Jakubowicz, T., Pitossi, F., Maurer, F., and Hemmings, B. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4171-4175[Abstract/Free Full Text]
3. Bellacosa, A., Testa, J., Staal, S., and Tsichlis, P. (1991) Science 254, 274-277[Abstract/Free Full Text]
4. Downward, J. (1998) Curr. Opin. Cell Biol. 10, 262-267[CrossRef][Medline] [Order article via Infotrieve]
5. Peso, L. d., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. (1997) Science 278, 687-689[Abstract/Free Full Text]
6. Datta, S., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. (1997) Cell 91, 231-241[CrossRef][Medline] [Order article via Infotrieve]
7. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. (1996) Cell 87, 619-628[CrossRef][Medline] [Order article via Infotrieve]
8. Meier, R., Alessi, D., Cron, P., Andjelkovic, M., and Hemmings, B. (1997) J. Biol. Chem. 272, 30491-30497[Abstract/Free Full Text]
9. Andjelkovic, M., Alessi, D., Meier, R., Fernandez, A., Lamb, N., Frech, M., Cron, P., Cohen, P., Lucocq, J., and Hemmings, B. (1997) J. Biol. Chem. 272, 31515-31524[Abstract/Free Full Text]
10. Montminy, M. (1997) Annu. Rev. Biochem. 66, 807-822[CrossRef][Medline] [Order article via Infotrieve]
11. Gonzalez, G. A., and Montminy, M. R. (1989) Cell 59, 675-680[CrossRef][Medline] [Order article via Infotrieve]
12. Yamamoto, K. K., Gonzalez, G. A., Biggs, W. H., III, and Montminy, M. R. (1988) Nature 334, 494-498[CrossRef][Medline] [Order article via Infotrieve]
13. Ginty, D., Bonni, A., and Greenberg, M. (1994) Cell 77, 713-725[CrossRef][Medline] [Order article via Infotrieve]
14. Sun, P., Enslen, H., Myung, P., and Maurer, R. (1994) Genes Dev. 8, 2527-2539[Abstract/Free Full Text]
15. Matthews, R., Guthrie, C., Wailes, L., Zhao, X., Means, A., and McKnight, G. (1994) Mol. Cell. Biol. 14, 6107-6116[Abstract/Free Full Text]
16. Tan, Y., Rouse, J., Zhang, A., Cariati, S., Cohen, P., and Comb, M. (1996) EMBO J. 15, 4629-4642[Medline] [Order article via Infotrieve]
17. Nantel, F., Monaco, L., Foulkes, N., Masquilier, D., LeMeur, M., Henriksen, K., Dierich, A., Parvinen, M., and Sassone-Corsi, P. (1996) Nature 380, 159-162[CrossRef][Medline] [Order article via Infotrieve]
18. Blendy, J., Kaestner, K., Weinbauer, G., Nieschlag, E., and Schutz, G. (1996) Nature 380, 162-165[CrossRef][Medline] [Order article via Infotrieve]
19. Barton, K., Muthusamy, N., Chanyangam, M., Fischer, C., Clendenin, C., and Leiden, J. (1996) Nature 379, 81-85[CrossRef][Medline] [Order article via Infotrieve]
20. Franke, T., Yang, S., Chan, T., Datta, K., Kazlauskas, A., Morrison, D., Kaplan, D., and Tsichlis, P. (1995) Cell 81, 727-736[CrossRef][Medline] [Order article via Infotrieve]
21. Brindle, P., Nakajima, T., and Montminy, M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10521-10525[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. A. Mena and J. Garcia de Yebenes Glial Cells as Players in Parkinsonism: The "Good," the "Bad," and the "Mysterious" Glia Neuroscientist, December 1, 2008; 14(6): 544 - 560. [Abstract] [PDF]

				M. H. Gao, T. Tang, T. Guo, A. Miyanohara, T. Yajima, K. Pestonjamasp, J. R. Feramisco, and H. K. Hammond Adenylyl Cyclase Type VI Increases Akt Activity and Phospholamban Phosphorylation in Cardiac Myocytes J. Biol. Chem., November 28, 2008; 283(48): 33527 - 33535. [Abstract] [Full Text] [PDF]

				K. Ohori, T. Miura, M. Tanno, T. Miki, T. Sato, S. Ishikawa, Y. Horio, and K. Shimamoto Ser9 phosphorylation of mitochondrial GSK-3{beta} is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2079 - H2086. [Abstract] [Full Text] [PDF]

				D. Mahadevan, G. Powis, E. A. Mash, B. George, V. M. Gokhale, S. Zhang, K. Shakalya, L. Du-Cuny, M. Berggren, M. A. Ali, et al. Discovery of a novel class of AKT pleckstrin homology domain inhibitors Mol. Cancer Ther., September 1, 2008; 7(9): 2621 - 2632. [Abstract] [Full Text] [PDF]

				H.-S. Seo, D. D. Liu, B. N. Bekele, M.-K. Kim, K. Pisters, S. M. Lippman, I. I. Wistuba, and J. S. Koo Cyclic AMP Response Element-Binding Protein Overexpression: A Feature Associated with Negative Prognosis in Never Smokers with Non-Small Cell Lung Cancer Cancer Res., August 1, 2008; 68(15): 6065 - 6073. [Abstract] [Full Text] [PDF]

				K. M. Ansari, J. E. Rundhaug, and S. M. Fischer Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016. [Abstract] [Full Text] [PDF]

				K. E Corcoran, A. Malhotra, C. A Molina, and P. Rameshwar Stromal-derived factor-1{alpha} induces a non-canonical pathway to activate the endocrine-linked Tac1 gene in non-tumorigenic breast cells J. Mol. Endocrinol., March 1, 2008; 40(3): 113 - 123. [Abstract] [Full Text] [PDF]

				I. Arany, J. Herbert, Z. Herbert, and R. L. Safirstein Restoration of CREB function ameliorates cisplatin cytotoxicity in renal tubular cells Am J Physiol Renal Physiol, March 1, 2008; 294(3): F577 - F581. [Abstract] [Full Text] [PDF]

				S. Aggarwal, S.-W. Kim, S.-H. Ryu, W.-C. Chung, and J. S. Koo Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding Protein Cancer Res., February 15, 2008; 68(4): 981 - 988. [Abstract] [Full Text] [PDF]

				A. Belkhiri, A. A. Dar, A. Zaika, M. Kelley, and W. El-Rifai t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism Cancer Res., January 15, 2008; 68(2): 395 - 403. [Abstract] [Full Text] [PDF]

				M. Sakaguchi, H. Sonegawa, H. Murata, M. Kitazoe, J.-i. Futami, K. Kataoka, H. Yamada, and N.-h. Huh S100A11, an Dual Mediator for Growth Regulation of Human Keratinocytes Mol. Biol. Cell, January 1, 2008; 19(1): 78 - 85. [Abstract] [Full Text] [PDF]

				J. Shao, M.K. Washington, R. Saxena, and H. Sheng Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin Carcinogenesis, December 1, 2007; 28(12): 2476 - 2483. [Abstract] [Full Text] [PDF]

				M. Ishida, T. Mitsui, K. Yamakawa, N. Sugiyama, W. Takahashi, H. Shimura, T. Endo, T. Kobayashi, and J. Arita Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1529 - E1537. [Abstract] [Full Text] [PDF]

				S.-W. Kim, J. S. Hong, S.-H. Ryu, W.-C. Chung, J.-H. Yoon, and J. S. Koo Regulation of Mucin Gene Expression by CREB via a Nonclassical Retinoic Acid Signaling Pathway Mol. Cell. Biol., October 1, 2007; 27(19): 6933 - 6947. [Abstract] [Full Text] [PDF]

				M. Pertusa, C. Morenilla-Palao, C. Carteron, F. Viana, and H. Cabedo Transcriptional Control of Cholesterol Biosynthesis in Schwann Cells by Axonal Neuregulin 1 J. Biol. Chem., September 28, 2007; 282(39): 28768 - 28778. [Abstract] [Full Text] [PDF]

				G. S. Huggins, J. J. Lepore, S. Greytak, R. Patten, R. McNamee, M. Aronovitz, P. J. Wang, and G. L. Reed The CREB leucine zipper regulates CREB phosphorylation, cardiomyopathy, and lethality in a transgenic model of heart failure Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1877 - H1882. [Abstract] [Full Text] [PDF]

				H. Konishi, K. Namikawa, K. Shikata, Y. Kobatake, T. Tachibana, and H. Kiyama Identification of Peripherin as a Akt Substrate in Neurons J. Biol. Chem., August 10, 2007; 282(32): 23491 - 23499. [Abstract] [Full Text] [PDF]

				D. Flugel, A. Gorlach, C. Michiels, and T. Kietzmann Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1{alpha} and Mediates Its Destabilization in a VHL-Independent Manner Mol. Cell. Biol., May 1, 2007; 27(9): 3253 - 3265. [Abstract] [Full Text] [PDF]

				A. Moeenrezakhanlou, D. Nandan, L. Shephard, and N. E. Reiner 1{alpha},25-Dihydroxycholecalciferol activates binding of CREB to a CRE site in the CD14 promoter and drives promoter activity in a phosphatidylinositol-3 kinase-dependent manner J. Leukoc. Biol., May 1, 2007; 81(5): 1311 - 1321. [Abstract] [Full Text] [PDF]

				A. P. Kumar, S. Bhaskaran, M. Ganapathy, K. Crosby, M. D. Davis, P. Kochunov, J. Schoolfield, I-T. Yeh, D. A. Troyer, and R. Ghosh Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract Clin. Cancer Res., May 1, 2007; 13(9): 2784 - 2794. [Abstract] [Full Text] [PDF]

				L. Yang, M. Sun, X.-m. Sun, G. Z. Cheng, S. V. Nicosia, and J. Q. Cheng Akt Attenuation of the Serine Protease Activity of HtrA2/Omi through Phosphorylation of Serine 212 J. Biol. Chem., April 13, 2007; 282(15): 10981 - 10987. [Abstract] [Full Text] [PDF]

				N. P. Shanware, A. T. Trinh, L. M. Williams, and R. S. Tibbetts Coregulated Ataxia Telangiectasia-mutated and Casein Kinase Sites Modulate cAMP-response Element-binding Protein-Coactivator Interactions in Response to DNA Damage J. Biol. Chem., March 2, 2007; 282(9): 6283 - 6291. [Abstract] [Full Text] [PDF]

				T. Nagashima, H. Shimodaira, K. Ide, T. Nakakuki, Y. Tani, K. Takahashi, N. Yumoto, and M. Hatakeyama Quantitative Transcriptional Control of ErbB Receptor Signaling Undergoes Graded to Biphasic Response for Cell Differentiation J. Biol. Chem., February 9, 2007; 282(6): 4045 - 4056. [Abstract] [Full Text] [PDF]

				F. Vandermoere, I. E. Yazidi-Belkoura, Y. Demont, C. Slomianny, J. Antol, J. Lemoine, and H. Hondermarck Proteomics Exploration Reveals That Actin Is a Signaling Target of the Kinase Akt Mol. Cell. Proteomics, January 1, 2007; 6(1): 114 - 124. [Abstract] [Full Text] [PDF]

				S. Schiekofer, I. Shiojima, K. Sato, G. Galasso, Y. Oshima, and K. Walsh Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure Physiol Genomics, October 11, 2006; 27(2): 156 - 170. [Abstract] [Full Text] [PDF]

				Y. Tsujita, J. Muraski, I. Shiraishi, T. Kato, J. Kajstura, P. Anversa, and M. A. Sussman Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy PNAS, August 8, 2006; 103(32): 11946 - 11951. [Abstract] [Full Text] [PDF]

				C. V. Garat, D. Fankell, P. F. Erickson, J. E.-B. Reusch, N. N. Bauer, I. F. McMurtry, and D. J. Klemm Platelet-Derived Growth Factor BB Induces Nuclear Export and Proteasomal Degradation of CREB via Phosphatidylinositol 3-Kinase/Akt Signaling in Pulmonary Artery Smooth Muscle Cells. Mol. Cell. Biol., July 1, 2006; 26(13): 4934 - 4948. [Abstract] [Full Text] [PDF]

				L. de la Pena, W. E. Burgan, D. J. Carter, M. G. Hollingshead, M. Satyamitra, K. Camphausen, and P. J. Tofilon Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1504 - 1510. [Abstract] [Full Text] [PDF]

				F. Vandermoere, I. El Yazidi-Belkoura, C. Slomianny, Y. Demont, G. Bidaux, E. Adriaenssens, J. Lemoine, and H. Hondermarck The Valosin-containing Protein (VCP) Is a Target of Akt Signaling Required for Cell Survival J. Biol. Chem., May 19, 2006; 281(20): 14307 - 14313. [Abstract] [Full Text] [PDF]

				Y. Hasegawa, M. Morioka, S. Hasegawa, J. Matsumoto, T. Kawano, Y. Kai, S. Yano, K. Fukunaga, and J.-i. Kuratsu Therapeutic Time Window and Dose Dependence of Neuroprotective Effects of Sodium Orthovanadate following Transient Middle Cerebral Artery Occlusion in Rats J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 875 - 881. [Abstract] [Full Text] [PDF]

N. Dronadula, F. Rizvi, E. Blaskova, Q. L